2013
DOI: 10.18632/oncotarget.1538
|View full text |Cite
|
Sign up to set email alerts
|

Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies

Abstract: Cadherin-11 (CDH11), associated with epithelial to mesenchymal transformation in development, poor prognosis malignancies and cancer stem cells, is also a major therapeutic target in rheumatoid arthritis (RA). CDH11 expressing basal-like breast carcinomas and other CDH11 expressing malignancies exhibit poor prognosis. We show that CDH11 is increased early in breast cancer and ductal carcinoma in-situ. CDH11 knockdown and antibodies effective in RA slowed the growth of basal-like breast tumors and decreased pro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
49
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 57 publications
(53 citation statements)
references
References 44 publications
4
49
0
Order By: Relevance
“…2023, 44–48 Furthermore, Cad-11 promotes osteogenic differentiation in the context of bone growth and development and additionally plays a role in myofibroblastic activation in dermal and pulmonary fibrosis. 4951 Cad-11 provides the necessary cell-cell tension for aggregation and calcification of valvular myofibroblasts, 25 likely mediated by RhoA and favoring a pro-calcific environment as we show here.…”
Section: Discussionmentioning
confidence: 99%
“…2023, 44–48 Furthermore, Cad-11 promotes osteogenic differentiation in the context of bone growth and development and additionally plays a role in myofibroblastic activation in dermal and pulmonary fibrosis. 4951 Cad-11 provides the necessary cell-cell tension for aggregation and calcification of valvular myofibroblasts, 25 likely mediated by RhoA and favoring a pro-calcific environment as we show here.…”
Section: Discussionmentioning
confidence: 99%
“…In the context of cancer, OB-cadherin expression is associated with increased migration and metastasis, especially metastasis to bone (Deng et al, 2013). As cell differentiation and migration in cancer and inflammatory disease show some similarities, OB-cadherin has been proposed as a common, possibly therapeutic, target for both types of disease (Assefnia et al, 2014). OB-cadherin plays an important role in inflammation in rheumatoid arthritis; it stimulates synovial fibroblasts to release proinflammatory cytokines upon cadherin engagement (Chang et al, 2011;Ding et al, 2014).…”
Section: Conclusion and Future Challengesmentioning
confidence: 99%
“…OB-cadherin plays an important role in inflammation in rheumatoid arthritis; it stimulates synovial fibroblasts to release proinflammatory cytokines upon cadherin engagement (Chang et al, 2011;Ding et al, 2014). Celecoxib, a pharmacological inhibitor of Cox-2 that inhibits inflammation during rheumatoid arthritis, has been shown to bind to OB-cadherin (Assefnia et al, 2014). Inflammation often leads to fibrosis, which is mediated by activated MyoFBs.…”
Section: Conclusion and Future Challengesmentioning
confidence: 99%
“…Dysregulated Cad-11 expression contributes to inflammation, cartilage degradation, and metastasis in diseases such as pulmonary fibrosis, rheumatoid arthritis, and multiple cancer types (Assefnia et al, 2014; Lee et al, 2007; Schneider et al, 2012; Tomita et al, 2000). Cad-11 also plays important roles in both cellular migration and differentiation in development, in particular through mediating collective migration and fate specification in neural crest mesenchyme (Becker et al, 2013; Borchers et al, 2001; Kashef et al, 2009).…”
Section: Introductionmentioning
confidence: 99%